Table 2: Pharmacological characteristics of commonly abused opioid drugs.
Characteristics of opioid drugs related to abuse liability are given for commonly abused or high-abuse-potential opioids. Among factors thought to influence drug likeability are relative potency (as characterized by opioid receptor kinetics), time to onset of drug effect, and duration of drug effect. Equivalent dosages of drug by route of administration is also provided for consideration (based upon 10 mg intravenous morphine as comparator), although there is considerable yet minor disagreement between available equivalency tables, and inter-individual variabilities in subjective experiences cannot be easily accounted for. Data sources for comparative data are indicated by superscript corresponding to references listed below. The designation of NA indicates that the respective data was not found or was unavailable.
Drug | Receptor Affinity (Ki / nM)[94, 135, 136] | Route of Administration | Equivalent Dose[137]# | Onset[137–141] | Duration[137–141] | Half life[141, 142] | ||
---|---|---|---|---|---|---|---|---|
MOR | DOR | KOR | ||||||
heroin | see morphine | see morphine | see morphine | insufflation | 20–35 mg | 10–15 min | 3–6 hr | >2–3.5 hr |
smoked | 15–25 mg | 5–10 min | 3–5 hr | |||||
intravenous | 5–10 mg | 0–5 min | 4–5 hr | |||||
hydrocodone | 11.1 | 962 | 501 | oral | 25 mg | 10–20 min | 4–8 hr | 3.3–4.4 hr |
Intravenous | NA | < 5 min | ~ 2 hr | |||||
morphine | 2.48 ; 14.0 | 290 ; >1000 | 46.8 ; 538 | oral | 25 mg | <30 min | ~4 hr | 2–3.5 hr |
insufflation | 15–20 mg | 10–30 min | 4–5 hr | |||||
IV / IM | 10 m | <1 min | 2–4 hr | |||||
oxymorphone | 0.78 | 50 | 137 | oral | 15 mg | 15–30 min | 3–4 hr | 7–9 hr |
intravenous | 1 mg | NA | NA | |||||
oxycodone | 8.69 | 901 | >1000 | oral | 12 mg | 10–15 min | 3–6 hr | 2–3 hr |
intravenous | 8.4 mg[143] | < 5 min | ~ 6 hr | |||||
hydromorphone | 0.47 | 18.5 | 24.9 | Oral | 5 mg | 15–30 min | 4–5 hr | 2–3 hr |
intravenous | 2 mg | <5 min | 2–3 hr | |||||
fentanyl | 0.39 | >1000 | 255 | intranasal | 25–50 μg | 5–15 min | 1–4 hr | 3–4 hr |
intravenous | 0.1 mg | 2 min | ~ 1 hr |
ClinCalc (online resource) accessed Oct. 2019 at https://clincalc.com/Opioids/